Sanofi ADR [SNY] stock is trading at $47.65, up 1.04%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The SNY shares have gain 5.12% over the last week, with a monthly amount drifted -0.83%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Sanofi ADR [NASDAQ: SNY] stock has seen the most recent analyst activity on September 08, 2025, when Morgan Stanley upgraded its rating to a Overweight but kept the price target unchanged to $58 for it. Previously, Deutsche Bank upgraded its rating to Buy on September 02, 2025. On August 08, 2025, upgrade upgraded it’s rating to Overweight. Exane BNP Paribas started tracking the stock assigning a Outperform rating and suggested a price target of $65 on April 15, 2025. Goldman initiated its recommendation with a Neutral and recommended $65 as its price target on March 21, 2025. Deutsche Bank upgraded its rating to Hold for this stock on January 30, 2025. In a note dated July 26, 2024, Argus reiterated an Buy rating on this stock and boosted its target price from $55 to $60.
Sanofi ADR [SNY] stock has fluctuated between $44.73 and $60.12 over the past year. Currently, Wall Street analysts expect the stock to reach $56 within the next 12 months. Sanofi ADR [NASDAQ: SNY] shares were valued at $47.65 at the most recent close of the market. An investor can expect a potential return of 17.52% based on the average SNY price forecast.
Analyzing the SNY fundamentals
Gross Profit Margin for this corporation currently stands at 0.72% with Operating Profit Margin at 0.37%, Pretax Profit Margin comes in at 0.31%, and Net Profit Margin reading is 0.21%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.12 and Total Capital is 0.16. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.32.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 47.36 points at the first support level, and at 47.08 for the second support level. However, for the 1st resistance point, the stock is sitting at 47.81, and for the 2nd resistance point, it is at 47.98.
Ratios To Look Out For
For context, Sanofi ADR’s Current Ratio is 1.27. As well, the Quick Ratio is 0.94, while the Cash Ratio is 0.53. Considering the valuation of this stock, the price to sales ratio is 2.68, the price to book ratio is 1.41 and price to earnings (TTM) ratio is 11.90.
